AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Lessons for Diagnosing and Managing Candidiasis in Critically Ill Patients

  • Credit:1.0 ACCENT
  • Duration: 1 hour
  • Date:MAR.23.2023 12:00 p.m. - 01:00 p.m.
  • Level: Basic

Price: $0.00

Member Price: $0.00

Your registration includes access to the recording on demand through March 31, 2024.


In this webinar, Dr. Cornelius (Neil) Clancy describes the difficulty in accurately identifying patients with deep-seated invasive candidiasis (IC) by discussing a clinical case study of a post-operative secondary fungal infection. He explains the limitations of using blood culture alone for detecting IC and provides an overview of recent clinical data on the performance of other diagnostic tests available for detecting candidemia and deep-seated infections. Dr. Clancy reviews data from a pilot study (n=125) in the MICU, comparing the sensitivities of both blood culture and culture-independent diagnostics and highlighting the impact to patient management. For healthcare professionals interested in implementing a non-culture solution, Dr. Clancy reviews the key considerations, benefits, and challenges to adopting new diagnostic methods for the detection of deep-seated IC.

Target Audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), and lab managers (supervisory and/or non-supervisory).

Learning Objectives

After attending this session, participants will be able to:

  • Discuss the clinical case study of a patient with candidemia and the likelihood of invasive candidiasis
  • Review the latest clinical data on the diagnosis of deep-seated candidiasis
  • Describe opportunities and barriers to the implementation of blood culture independent diagnostics and lessons for patient management


Cornelius ClancyCornelius J. Clancy, MD
Chief, Infectious Diseases, VA Pittsburgh Healthcare System
Professor of Medicine and Associate Chief, Infectious Diseases, University of Pittsburgh
Co-Director, Center for Healthcare Mycology and XDR Pathogen Lab, University of Pittsburgh
Pittsburgh, PA USA


AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported no relevant financial relationship:

  • Cornelius J. Clancy, MD


All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.


This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 4176. This activity was planned in accordance with ACCENT® Standards and Policies.


Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Sponsored by

T2 Biosystems Logo